jmogh market for any stock--but the biotechs rely on investors that are willing and able to see the future potential and not just not quarter's earnings.
It has happened before--and it will happen again. You accumulate shares when no one seemingly wants them. And sell when EVERYONE wants them.
FBIO has never been in a better place in their business plan. Cash flowing positive and a nice pipeline with milestones expected to be met over the next few months.